Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis

Since the beginning of the mass immunization of patients with multiple sclerosis (MS), many data on the efficacy and safety of COVID-19 vaccines have been produced. Considering that MS is an autoimmune disease and that some disease-modifying therapies (DMTs) could decrease the antibody response agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Maniscalco, Giorgia Teresa, Di Giulio Cesare, Daniele, Liguori, Valerio, Manzo, Valentino, Prestipino, Elio, Salvatore, Simona, Di Battista, Maria Elena, Moreggia, Ornella, Ziello, Antonio Rosario, Andreone, Vincenzo, Scavone, Cristina, Capuano, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342738/
https://www.ncbi.nlm.nih.gov/pubmed/37445269
http://dx.doi.org/10.3390/jcm12134236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342738/
https://www.ncbi.nlm.nih.gov/pubmed/37445269
http://dx.doi.org/10.3390/jcm12134236

Ejemplares similares